Representative images of Ki67 assay on HT29 xenograft tumour sections with illustrated treatments. Scale bar is 100 μm.
Supple. Fig. 4 Aptamer-guided DOX delivery reduced gross adverse effects. Body weight variation of tumour-bearing mice between day 1 and day 11 after treatment as indicated were recorded. Mice were treated with 1.5 μM of Apt-DOX/mouse or an equivalent dose of free DOX. Data shown are means ± SEM. (n=3, unless indicated otherwise). ** P < 0.01 compared with mice receiving free DOX.
6 Supple. Fig. 6 Supple. Fig. 6 Representative of confocal micrographs of TUNEL assay of cells with illustrated treatments. Scale bar is 100 μm.
Supple. Tables   Supple. Table 1 Cmax, maximum plasma concentration; t1/2β, elimination half-life; MRT, mean retention time; AUC, area under the plasma concentration-time curves; CL, total body clearance; Vss, steady state volume of distribution. *, P < 0.01; **, P < 0.001 compared with rats received free DOX (two-tailed Student's t-test).
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